Unicycive Therapeutics, Inc.
UNCY
$0.64
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.53M | -4.10M | 9.86M | -20.96M | -7.80M |
| Total Depreciation and Amortization | 134.00K | 123.00K | -113.00K | 284.00K | 82.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.14M | -1.15M | -16.17M | 12.33M | 2.16M |
| Change in Net Operating Assets | 1.70M | -4.13M | 108.00K | 1.89M | 1.12M |
| Cash from Operations | -6.55M | -9.25M | -6.32M | -6.46M | -4.44M |
| Capital Expenditure | -22.00K | -24.00K | -20.00K | -6.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.00K | -24.00K | -20.00K | -6.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 683.00K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 50.00M | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00 | -1.10M | -- | -- |
| Other Financing Activities | -318.00K | -157.00K | 284.00K | -4.31M | -205.00K |
| Cash from Financing | 365.00K | -157.00K | -811.00K | 45.69M | -205.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.21M | -9.43M | -7.15M | 39.23M | -4.64M |